Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy
about
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liverChromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.Generation of functional CD8+ T cells by human dendritic cells expressing glypican-3 epitopes.Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver.Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.A novel, rapid, and sensitive homogeneous sandwich detection method of Glypican-3 as a serum marker for hepatocellular carcinoma.Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice.MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3.Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
P2860
Q26772321-31337FD0-188B-4578-8D55-8B752CFFFD11Q26998606-100F166F-5C06-408C-BB99-53D505140D58Q36598885-9574CDC0-4BD1-49BA-B234-9364C939EA8FQ37055721-75ACBB8D-F811-4B94-8633-8D19D4D465FCQ37538453-F80D4777-05DE-4D63-BA0E-3CA6F48E2153Q39704344-8661B9B4-553C-4341-ACBC-5BBE1559D977Q41140599-071EE8D3-CA13-4005-A547-535982A96DD5Q42114895-C970AAE6-2361-422F-89F5-A2B819ACFAEEQ42571598-5A254249-12A6-43C4-BBDB-186F31F66697Q47246246-1687F1EF-80D5-4DC7-AA4C-D157BEABE5AEQ50095439-52C7D785-518E-4522-98B8-053843A0FBFAQ50978081-A37E1078-9785-4961-A8FB-689630BCB5F3Q51052957-5E214FF4-052B-4051-A24F-59DB6370CADAQ51445413-93A36D32-7799-4781-8490-FAA1BE4556D5Q53876627-641A20B3-8C9B-48CE-A94E-DBCB5F04D635
P2860
Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@ast
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@en
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@nl
type
label
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@ast
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@en
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@nl
prefLabel
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@ast
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@en
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@nl
P2093
P356
P1476
Value of glypican 3 immunostai ...... lar carcinoma on needle biopsy
@en
P2093
Florencia Anatelli
Hanlin L Wang
Shang-Tian Chuang
Ximing J Yang
P304
P356
10.1309/WMB5PX57Y4P8QCTY
P407
P577
2008-08-01T00:00:00Z